Devyser achieves breakthrough in the US with cystic fibrosis NGS test
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Rapid aneuploidy analysis | October 3, 2022
The X chromosome counting markers define non-variable sequences present on the X chromosome and an autosomal chromosome that are amplified using identical primers. The amplified marker fragments are separated according to length and the X chromosomal copy number is determined by fragment area ratio calculation.
The Devyser QF-PCR kits includes several X-chromosome counting markers for reliable detection of Turner syndrome.
The inability of STR marker analysis to distinguish subjects who are homozygous or monosomic is a major shortcoming when testing for sex chromosome abnormalities. When STRs specific for chromosome X are used, some samples from normal XX females may show homozygous QF PCR patterns, indistinguishable from those produced by samples with a single X, as in Turner syndrome.
The T1, T2 and T3 markers are non-polymorphic (non-STR) X chromosome counting markers that may be used to determine the number of X chromosomes when monosomy X is suspected. These markers define sequences present on the X chromosome and an autosomal chromosome that are amplified using identical primers. The amplified marker fragments are separated according to length and the X chromosomal copy number is determined by fragment area ratio calculation. In a normal female an X chromosome counting marker area ratio of 1:1 is expected. In normal males and females with monosomy X a 2:1 ratio is expected (see figure below).
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read More
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
Read More
Read More